By Allison Rosenzweig, PhD

PanCAN mourns the loss of Gloria Petersen, PhD.

Results from the NAPOLI 3 clinical trial were presented at the ASCO GI Symposium.

Find out how BRCA mutations can impact pancreatic cancer risk and treatment options.

The PanCAN Scientific Summit allowed for data-sharing, discussion and collaboration.

PanCAN is investing nearly $25 million in conducting and funding research in 2022.

Clinical trial results and PanCAN’s initiatives were highlighted at major meeting.

A patient who responded well to a novel immunotherapy approach is in the news.

Learn about two PanCAN-funded projects with promising results.

PanCAN will provide $3.8 million to Verastem Oncology for innovative clinical trial.

A recent workshop yielded new insights into how to improve treatment for cachexia.

Dr. Rodriguez discusses inequities in access to genetic testing and education.

Patients – and their safety – are at the center of every decision.

Get the latest news from PanCAN’s Know Your Tumor and other clinical trial progress.

Clinical trials are testing new treatment approaches and becoming more innovative.

Thanks to you, we’re making progress toward early detection and better treatments.

Learn about COVID-19 vaccines and booster shots from PanCAN’s chief medical officer.

PanCAN grantees, advisers, industry members and guests gathered to discuss research.

Conference featured exciting new results, robust discussion and a look to the future.

We spoke with experts about diversity and equity in clinical trials and patient care.

Data published from PanCAN’s Patient Registry show power of patient-reported outcomes

PanCAN and partners published a study about RAF alterations in patients’ tumors.

Meet this year’s research grant recipients and learn about their projects.

Dr. Tempero will help guide scientific and clinical initiatives and priorities.

Editor’s note: Originally published in February 2021, we’ve updated this article to include the exciting news that the first drug […]
READ MORE

A panel of experts discusses screening tests to find pancreatic cancer earlier.

The Precision Promise Supportive Care Committee published a paper on pain management.

Chief Science Officer Lynn Matrisian shares her priorities, proudest accomplishments.

Diabetes can be both a risk factor and an early symptom of pancreatic cancer.

Earlier detection leads to more treatment options and improved survival.

PanCAN and partners published new projections about cancer cases and deaths today.

Editor’s note: In honor of International Women’s Day, we are celebrating several PanCAN research grant recipients whose experiences in different […]
READ MORE

Editor’s note: In honor of Black History Month, PanCAN is celebrating the contributions of our community’s Black supporters and the […]
READ MORE

Awareness of both the risk factors and symptoms of the disease is important.

The 2021 Gastrointestinal (GI) Cancers Symposium recently brought together oncologists, researchers, patients and patient advocates, including the Pancreatic Cancer Action […]
READ MORE

“Life is basically back to normal.” These are the words of five-year stage IV pancreatic cancer survivor, Lynne Holcomb, of […]
READ MORE

Every day in 2021, 166 Americans will learn that they have pancreatic cancer. That’s 60,430 people who are predicted to […]
READ MORE

Editor’s note: In today’s edition of our Year in Review series, we’re looking back at the wins you made possible […]
READ MORE

Editor’s note: Today’s article looks back at scientific and clinical advances made in 2020 and kicks off our Year in […]
READ MORE

Thousands of advocates delivered a strong message to Capitol Hill: Make pancreatic cancer a national priority. And Congress responded. Congress […]
READ MORE

Tips to keep you and your loved ones safe with vaccines, masks, tests and planning.

Robert Duran was told he had pancreatic cancer – not just once, or twice. Three times. PanCAN’s Patient Services has supported him every step of the way […]

Get a recap of our World Pancreatic Cancer Day webinar featuring an expert panel discussing the latest in clinical research […]

After losing her mom and uncle to pancreatic cancer, Nancy made an impact by donating to PanCAN to fund Ingunn’s early-career research […]

We join the world in mourning the death of Alex Trebek, who had stage IV pancreatic cancer. The longtime host […]
READ MORE

If you have a first-degree relative (parent, child or sibling) who was diagnosed with pancreatic cancer, you may have an […]
READ MORE

The Pancreatic Cancer Action Network’s (PanCAN) Patient Registry is a global online database created to look for patterns in treatments, […]
READ MORE

Editor’s note: We recently announced the recipients of the Pancreatic Cancer Action Network’s (PanCAN) 2020 research grants. Now we’d like […]
READ MORE

Editor’s note: We recently announced the recipients of the Pancreatic Cancer Action Network’s (PanCAN) 2020 research grants. Now we’d like […]
READ MORE

Editor’s note: We recently announced the recipients of the Pancreatic Cancer Action Network’s (PanCAN) 2020 research grants. Now we’d like […]
READ MORE

The Pancreatic Cancer Action Network’s (PanCAN) Annual Scientific Summit may have looked different this year, but some things stayed the […]
READ MORE

Applications are now being accepted for Pancreatic Cancer Action Network (PanCAN) Career Development Awards. PanCAN has awarded Career Development Awards […]
READ MORE

Editor’s note: We recently announced the recipients of the Pancreatic Cancer Action Network’s (PanCAN) 2020 research grants. Now we’d like […]
READ MORE

Editor’s note: In March, we published an article about coronavirus disease (COVID-19) and how it impacts pancreatic cancer patients. As […]
READ MORE

Editor’s note: We recently announced the recipients of the Pancreatic Cancer Action Network’s (PanCAN) 2020 research grants. Now we’d like […]
READ MORE

In its latest guidelines for the treatment of patients with metastatic pancreatic cancer, the American Society of Clinical Oncology (ASCO) […]
READ MORE

Editor’s note: We recently announced the recipients of the Pancreatic Cancer Action Network’s (PanCAN) 2020 research grants. Now we’d like […]
READ MORE

Today, thanks to Pancreatic Cancer Action Network’s (PanCAN) tireless advocates, the U.S. House of Representatives passed a Department of Defense […]
READ MORE

Editor’s note: “Jeopardy!” host Alex Trebek and former Sen. Harry Reid have publicly mentioned being treated with an experimental immunotherapy […]
READ MORE

Editor’s note: We recently announced the recipients of the Pancreatic Cancer Action Network’s (PanCAN) 2020 research grants. Now we’d like […]
READ MORE

Editor’s note: We recently announced the recipients of the Pancreatic Cancer Action Network’s (PanCAN) 2020 research grants. Now we’d like […]
READ MORE

Editor’s note: We recently announced the recipients of the Pancreatic Cancer Action Network’s (PanCAN) 2020 research grants. Now we’d like […]
READ MORE

Thanks to the generosity of our donors and supporters, we are pleased to announce that the Pancreatic Cancer Action Network […]
READ MORE

The American Association of Cancer Research (AACR) has awarded Yoshiyuki Majima, PhD, MPH, its prestigious Distinguished Public Service Award. Majima […]
READ MORE

You are your own best advocate. If you’ve been diagnosed with a disease like pancreatic cancer, it’s important to get […]
READ MORE

The theme for the 2020 American Society of Clinical Oncology’s (ASCO) Annual Meeting was “Unite & Conquer: Accelerating Progress Together.” […]
READ MORE

People who smoke cigarettes are two times as likely to develop pancreatic cancer.

Monday, June 15Join us for our live, free Advocacy Week Kick-off Event featuring special guests! Hear from advocates and special […]
READ MORE

Christos Fountzilas, MD, is proud to be a member of the Pancreatic Cancer Action Network’s (PanCAN) Patient Champions program. “PanCAN […]
READ MORE

Editor’s note: May is National Cancer Research Month, which provides an opportunity to highlight the incredible scientific and clinical research […]
READ MORE

All the way across the country from one another, two pancreatic cancer researchers made similar discoveries in their labs. Rushika […]
READ MORE

Because of the coronavirus disease (COVID-19) pandemic, many Americans and people around the world have been instructed to practice social […]
READ MORE

Editor’s note: This week’s Friday Fix focuses on anemia, a condition when your red blood cell count is too low. […]
READ MORE

Pancreatic Cancer Action Network (PanCAN) research grantee Kenneth Olive, PhD, is dedicated to keeping his lab as connected as possible […]
READ MORE

Editor’s note: Because of the current coronavirus disease (COVID-19) pandemic, we’re focusing this week’s Friday Fix on foods and behaviors […]
READ MORE

Editor’s note: Please continue to follow the U.S. Centers for Disease Control (CDC) for up-to-date information and guidelines about coronavirus […]
READ MORE

Editor’s note: Please continue to follow the U.S. Centers for Disease Control (CDC) for up to date information and guidelines […]
READ MORE

Editor’s note, March 16, 2020: The coronavirus disease (COVID-19) pandemic is changing daily. Please watch the U.S. Centers for Disease […]
READ MORE

The Pancreatic Cancer Action Network’s (PanCAN) Know Your Tumor® precision medicine service can help pancreatic cancer patients live longer. Know […]
READ MORE

Learn more about pancreatic neuroendocrine tumors or PNETS.

The American Society of Clinical Oncology (ASCO) released its “Clinical Cancer Advances 2020” report earlier this week – aptly timed […]
READ MORE

“Accelerating Personalized Care” was the theme for the 2020 Gastrointestinal (GI) Cancers Symposium, which took place Jan. 23-25 in San […]
READ MORE

Editor’s note: During January, Pancreatic Cancer Clinical Trials Awareness Month, we are featuring a “Shedding Light on Clinical Trials” series […]
READ MORE

Editor’s note: January is Pancreatic Cancer Clinical Trials Awareness Month. Throughout the month, we will feature a “Shedding Light on […]
READ MORE

For the first time ever, the five-year survival rate for pancreatic cancer has reached double digits. American Cancer Society’s Cancer […]
READ MORE

Editor’s note: This article kicks off our 2019 Year in Review series – highlighting the research advancements that you – […]
READ MORE

New research suggests that pancreatic tumors can be classified into two broad categories – and this information can help guide […]
READ MORE

The goal of cancer treatment is to identify – and attack – vulnerabilities that make cancer cells different from healthy […]
READ MORE

In response to the disease’s impact on his constituents in Alabama, Sen. Doug Jones (D-AL) presided over a hearing entitled, […]
READ MORE

We are extremely sad to share that Pancreatic Cancer Action Network (PanCAN) research grant recipient David Boothman, PhD, died on […]
READ MORE

The results from two phase III clinical trials for pancreatic cancer patients were recently announced. Both Lilly’s SEQUOIA and Halozyme’s […]
READ MORE

People with pancreatic cancer and a specific type of change – or mutation – in their DNA live longer when […]
READ MORE

Editor’s note: The Pancreatic Cancer Action Network’s (PanCAN) Annual Scientific Summit took place earlier this month in Coral Gables, Fla. […]
READ MORE

Editor’s note: We are deeply saddened to share that Adam Deal died of pancreatic cancer in December 2020. His advocacy […]
READ MORE

Editor’s note: We are deeply saddened to share that Adam Deal died of pancreatic cancer in December 2020. His advocacy […]
READ MORE

Clinical trials are necessary to determine whether a drug or treatment combination is safe, effective and an improvement over the […]
READ MORE

When immunology expert Ingunn Stromnes, PhD, assistant professor of microbiology and immunology at the University of Minnesota, unexpectedly discovered a […]
READ MORE

The U.S. Preventive Services Task Force (USPSTF) continues to recommend against population-wide screening for pancreatic cancer, as announced today on […]
READ MORE

Editor’s note: We recently announced the recipients of our 2019 research grants, awarded through a competitive, peer-review process. Now we’d […]
READ MORE

When the Pancreatic Cancer Action Network (PanCAN) launched its Know Your Tumor® precision medicine service, molecular profiling was offered for […]
READ MORE

How does someone trained in spin physics – the study of the “magnetic moment” of elementary particles – apply that […]
READ MORE

It’s Cancer Immunotherapy Month. Here, we discuss immunotherapy and pancreatic cancer.

Every pancreatic tumor – and every pancreatic cancer patient – is different. The Pancreatic Cancer Action Network (PanCAN) strongly recommends […]
READ MORE

The symptoms patients may experience leading up to their pancreatic cancer diagnosis – including weight loss, abdominal pain and changes […]
READ MORE

This year’s American Society of Clinical Oncology (ASCO) Annual Meeting has brought 40,000 oncologists and other cancer experts from around […]
READ MORE

A new treatment combination – combining chemotherapy and radiation therapy with a common blood pressure drug – has shown promise […]
READ MORE

The morning of Feb. 5, 2016, started like many for Gail. She got up early and headed to the gym […]
READ MORE

Editor’s note: We are very sad to share that Dr. Andy Hospodor also died of pancreatic cancer on June 19, […]
READ MORE

Simply put, the Pancreatic Cancer Action Network (PanCAN) would not exist without Pamela Acosta Marquardt.   “It all started with […]
READ MORE

Editor’s note: May is National Cancer Research Month, and we recently had the opportunity to speak with two leading pancreatic […]
READ MORE

As Pancreatic Cancer Action Network (PanCAN) supporters in Southern California gear up for PurpleStride Los Angeles on May 4, a […]
READ MORE

Nearly $178 million was invested in pancreatic cancer research by the National Cancer Institute (NCI) in 2017 – a 17 […]
READ MORE

Editor’s note: A study published last week has gotten some media attention, including this NBC News article that includes insights […]
READ MORE

“I’ve been attending the American Association for Cancer Research (AACR) annual meetings for several years, and this year’s conference was […]
READ MORE

A study published in Nature today describes how mutant KRAS impacts pancreatic cancer cells’ ability to gather nutrients – and […]
READ MORE

About 10 percent of pancreatic cancer cases are thought to be hereditary – caused by an inherited genetic alteration that […]
READ MORE

The largest-ever molecular analysis of pancreatic cancer tissue samples – from more than 3,500 patients – revealed some new clues […]
READ MORE

When Allison Perlis of Potomac, Md., first began experiencing symptoms of pancreatic cancer in early 2017, she dismissed them as […]
READ MORE

New donor-funded research published today in the journal Nature describes signals that prepare the liver in advance for pancreatic cancer […]
READ MORE

Editor’s note: Hear directly from pancreatic cancer researcher Kirsten Bryant, PhD, and Julie Fleshman, president and CEO of the Pancreatic […]
READ MORE

Editor’s note: In this Washington Post article, Nathaniel Brooks Horwitz wrote about his experience launching biopharmaceutical company Nivien Therapeutics in […]
READ MORE

“There is no way to sugarcoat the fact that pancreatic cancer is very difficult to treat,” begins an article recently […]
READ MORE

In addition to its annual Cancer Facts & Figures report, the American Cancer Society (ACS) releases cancer data specific to […]
READ MORE

Editor’s note: Our “It Starts with Someone” series chronicles all kinds of Pancreatic Cancer Action Network (PanCAN) supporters – volunteers, […]
READ MORE

Do you ever see scientific or medical headlines that sound too good to be true? Ask these questions to help […]
READ MORE

The American Society of Clinical Oncology (ASCO) has released their Clinical Cancer Advances 2019 report. The report outlines progress over […]
READ MORE

Pancreatic cancer is notoriously difficult to find in its earlier, and more treatable stages. For this reason, research teams across […]
READ MORE

A large group of Pancreatic Cancer Action Network (PanCAN) leadership and Scientific and Medical Affairs staff are attending the 2019 […]
READ MORE

Even before certain cells of the pancreas become cancer, changes occur in their ability to break down nutrients, according to […]
READ MORE

More than 56,700 Americans will be diagnosed with pancreatic cancer in 2019, today’s American Cancer Society Cancer Facts & Figures […]
READ MORE

Editor’s note: Today’s edition of the 2018 Year in Review series continues the topic of research. Yesterday’s article covered treatment […]
READ MORE

Editor’s note: Welcome to the first article in our 2018 Year in Review series! Over the next couple weeks, we’ll […]
READ MORE

Editor’s note: In light of Pancreatic Cancer Awareness Month and our focus on the importance of biomarker and genetic testing, […]
READ MORE

Editor’s note: Last year, we shared information about hereditary pancreatic cancer during November, Pancreatic Cancer Awareness Month. Since then, there […]
READ MORE

The American Society of Clinical Oncology (ASCO) and the National Comprehensive Cancer Network (NCCN) provide the healthcare community with current […]
READ MORE

The U.S. Food and Drug Administration (FDA) approved Vitrakvi® (larotrectinib) today for the treatment of any locally advanced or metastatic solid tumor, […]
READ MORE

The Atlantic’s People v. Cancer event took place Nov. 14, 2018, in New York City. The event featured a stellar […]
READ MORE

When asked whether alternative medicines alone could cure cancer, nearly 40 percent of Americans recently surveyed answered yes. “This is […]
READ MORE

In November, Pancreatic Cancer Awareness Month, the focus is on raising awareness about risk factors and symptoms of pancreatic cancer. […]
READ MORE

For eligible patients, surgery is the best option for long term survival of pancreatic cancer. Data show high volume surgeons […]
READ MORE

Editor’s note: Sadly, Gail Bamer died in July 2019. We are grateful to her for allowing her story to be […]
READ MORE

The Pancreatic Cancer Action Network (PanCAN) offers an Ask PanCAN Patient Services series to provide helpful tips and information about […]
READ MORE

Editor’s note: Our “It Starts with Someone” series chronicles all kinds of Pancreatic Cancer Action Network (PanCAN) supporters – volunteers, […]
READ MORE

The Pancreatic Cancer Action Network (PanCAN) has now delivered personalized molecular profiling reports to 1,000 pancreatic cancer patients through its […]
READ MORE

Thomas A. Steitz, PhD, died of pancreatic cancer on Oct. 9, 2018, at the age of 78, according to news […]
READ MORE

The 2018 Nobel Prize in Physiology or Medicine has been awarded to James (Jim) Allison, PhD, and Tasuku Honjo, MD, […]
READ MORE

“I was 7 years old when my dad’s mom, Gertrud, was diagnosed with breast cancer,” began Pamela Munster, MD, a […]
READ MORE

Editor’s note, Oct. 17, 2018: We are delighted to report that Rishab Jain won the Discovery Education 3M Young Scientist […]
READ MORE

When doctors told David Watson of Santa Monica, Calif., that he had type 2 diabetes in November 2016, he couldn’t […]
READ MORE

The International Agency for Research on Cancer (IARC) released new global cancer statistics on Sept. 12. Of the 18 million […]
READ MORE

Every year, the American Association for Cancer Research (AACR), the oldest and largest organization dedicated to advancing cancer research, publishes […]
READ MORE

In a study recently published in the prestigious Journal of Clinical Oncology, researchers investigated the accuracy of a biomarker panel […]
READ MORE

A biomarker is a substance found in the body that can be measured. The amount of a biomarker may vary […]
READ MORE

Editor’s note: We join the nation in mourning the death of Sen. John McCain to glioblastoma, an extremely aggressive form […]
READ MORE

The fitting theme for this year’s Pancreatic Cancer Action Network (PanCAN) Annual Scientific Summit, occurring Aug. 23-26, 2018, in San […]
READ MORE

Before Allison Lippman of Dallas met her now-husband, she was not convinced she wanted to date anyone. “I was turning […]
READ MORE

Editor’s note, March 2, 2020: Results published in Lancet Oncology from the Pancreatic Cancer Action Network’s (PanCAN) Know Your Tumor® […]
READ MORE

Editor’s note: On July 25, 2008, 10 years ago today, professor Randy Pausch, PhD, of “The Last Lecture” fame, died […]
READ MORE

This year, the Pancreatic Cancer Action Network (PanCAN) awarded eight prestigious research grants to scientists and clinicians in the United […]
READ MORE

Cancer immunotherapy involves efforts to harness the patient’s own immune system to recognize and attack tumor cells. To date, the […]
READ MORE

The Pancreatic Cancer Action Network (PanCAN) recently announced this year’s recipients of prestigious research grants. Funding decisions were made by […]
READ MORE

Published today in the esteemed Clinical Cancer Research, a journal of the American Association for Cancer Research, the Pancreatic Cancer […]
READ MORE

A pancreatic cancer diagnosis can lead to a lot of questions, including how to choose a healthcare team, deciding on […]
READ MORE

Today at National Pancreatic Cancer Advocacy Day, a prestigious panel of scientific and clinical leaders discussed key topics surrounding the […]
READ MORE

Every pancreatic tumor is different. The Pancreatic Cancer Action Network (PanCAN) strongly recommends molecular profiling of your tumor to help […]
READ MORE

Editor’s note: You may have heard breakthrough news that came out of the American Society of Clinical Oncology (ASCO) Annual […]
READ MORE

On day four of the American Society of Clinical Oncology (ASCO) Annual Meeting, results of two critically important phase III […]
READ MORE

Editor’s note: There is news coming out of the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place June […]
READ MORE

Many pancreatic cancer patients experience weight loss, which can be caused or made worse by treatment as well as the […]
READ MORE

The American Society of Clinical Oncology (ASCO) has updated their treatment guidelines for patients with metastatic pancreatic cancer, or disease […]
READ MORE

Today, the Annual Report to the Nation on the Status of Cancer was released. The report is prepared by the […]
READ MORE

A team of researchers from the University of California, San Diego (UCSD), recently published a study evaluating a new strategy […]
READ MORE

Editor’s note: You may have heard earlier this week on our website and from other media sources that former Senate […]
READ MORE

You may have spoken with friends or family members on chemotherapy, or seen TV or movie depictions of someone undergoing […]
READ MORE

If you had asked Jason Doles, PhD, five years ago where he anticipated he’d be today, he would not have […]
READ MORE

Editor’s note: Below we describe recent updates to the National Comprehensive Cancer Network’s (NCCN) guidelines for the treatment and management […]
READ MORE

Did you know that DNA gets its own day? It’s today! National DNA Day has been celebrated since 2003, when […]
READ MORE

The theme for this year’s American Association for Cancer Research (AACR) Annual Meeting, which took place earlier this week in […]
READ MORE

Announced at the American Association for Cancer Research (AACR) Annual Meeting in Chicago, a new study suggests that a popular […]
READ MORE

Editor’s note: Today is National Doctors’ Day, and we are celebrating the critical roles of various specialists in the diagnosis […]
READ MORE

Editor’s note: This is the second of three articles leading up to National Doctors’ Day on March 30. We are […]
READ MORE

Editor’s note: Leading up to National Doctors’ Day on March 30, we’re highlighting the critical roles of various medical disciplines […]
READ MORE

Scientists have known for quite some time that pancreatic tumors are surrounded by an especially dense and complex “stroma,” a […]
READ MORE

Editor’s note: Our “It Starts with Someone” series chronicles all kinds of Pancreatic Cancer Action Network (PanCAN) supporters – volunteers, […]
READ MORE

When a cyst is detected in someone’s pancreas, the first priority is characterizing the type of cyst – and determining […]
READ MORE

Patient safety is a top priority in all clinical trials.

About 95 percent of pancreatic cancer cases – and around 30 percent of all human cancers – have a mutation […]
READ MORE

“All Cancer Patients Should Have Access To Genomic Testing” is the title of a compelling article featured in Forbes earlier […]
READ MORE

The 2nd International Congress on Clinical Trials in Oncology and Hemato-Oncology (ICTO2018) took place earlier this week in Berlin. The […]
READ MORE

A pancreatic cancer diagnosis – and the side effects sometimes caused by treatments – can take an enormous toll on […]
READ MORE

Both Wantong Yao, MD, PhD, and Haoqiang Ying, MD, PhD, underwent medical training in China. They both became deeply interested […]
READ MORE

Today, the U.S. Food & Drug Administration (FDA) approved Lutathera® (lutetium-177 (177Lu)-Dotatate) for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs), […]
READ MORE

Editor’s note: You may have seen stories in the news and here on our website about a new blood test […]
READ MORE

Yesterday, a collaborative team of scientists, primarily from Johns Hopkins University, published a paper in the well regarded journal Science, […]
READ MORE

Two-time Pancreatic Cancer Action Network (PanCAN) research grant recipient, Timothy Wang, MD, set out to answer an unusual question: How […]
READ MORE

Today, the American Cancer Society (ACS) released its 2018 Cancer Facts & Figures, an annual report that analyzes cancer statistics […]
READ MORE

Editor’s note: Welcome to the second part of our 2017 research highlights recap (we’re pretty excited that it’s taking two […]
READ MORE

At the end of every year, Science magazine announces a Breakthrough of the Year – a discovery that revolutionized the […]
READ MORE

Editor’s note: This article is the first in our “Year in Review” series recapping the year’s top stories in pancreatic […]
READ MORE

The National Cancer Institute (NCI) recently funded four new teams of researchers through its Pancreatic Cancer Detection Consortium (PCDC). According […]
READ MORE

Akshay Mehta, MD, was in the middle of performing an orthopedic surgery when his first pancreatic cancer symptom arose. “I […]
READ MORE

Published in the Journal of Gastrointestinal Cancer, a recent survey of 150 oncologists showed a lack of compliance with evidence-based […]
READ MORE

About 5 to 10 percent of pancreatic cancer cases are considered to be hereditary or familial. “Hereditary disease generally means […]
READ MORE

Editor’s Note: Originally published in November 2017, this blog post was updated in May 2023. It is not unusual for […]
READ MORE

Pancreatic cancer researcher Kenneth Scott, PhD, associate professor of molecular and human genetics at Baylor College of Medicine, passed away […]
READ MORE

A multi-institutional research team, including Vinod Balachandran, MD, and Steven Leach, MD, set out to ask an important question: “What […]
READ MORE

In August 2017, oncologist Mark Lewis, MD, underwent a Whipple surgical procedure for his pancreatic neuroendocrine tumor (PNET). But his […]
READ MORE

Participation in the Pancreatic Cancer Action Network’s (PanCAN’s) Patient Registry has provided important insight into the prescription of, and patient […]
READ MORE

Among the many genetic mutations and molecular alterations that can be found in pancreatic tumors, there are four that are […]
READ MORE

Results from a study presented at the 25th United European Gastroenterology (UEG) Week meeting in Barcelona suggest that long-term, low-dose aspirin use […]
READ MORE

While most people are familiar with types 1 and 2 diabetes, there is a third, less common type, known as […]
READ MORE

Good nutritional care improves outcomes and is critical for a patient’s quality of life. The Pancreatic Cancer Action Network (PanCAN) […]
READ MORE

The Cancer Research & Oncology 2017 virtual conference will take place Oct. 11 to 12, beginning at 6 a.m. PDT. […]
READ MORE

An article published yesterday in Newsweek describes a European analysis that found cancer drugs are being approved without adequate evidence […]
READ MORE

In a forward-looking study of patients diagnosed with various types of cysts of the pancreas, researchers at the University of […]
READ MORE

Sometimes the most unexpected and unusual observations in the laboratory can lead to important results. Such was the case when […]
READ MORE

The American Association for Cancer Research (AACR) released its annual Cancer Progress Report earlier this week. “Research continues to be […]
READ MORE

When someone is diagnosed with cancer, battle metaphors often prevail – He is such a fighter! She will win this […]
READ MORE

The so-called breast cancer genes BRCA1 and BRCA2 were originally found to increase a woman’s risk of breast cancer when […]
READ MORE

Whether it’s hurricanes, storms, wildfires or earthquakes, we’re all vulnerable to the risk – and reality – of natural disasters. […]
READ MORE

Back when he was a postdoctoral researcher, grantee Kazuki Sugahara, MD, PhD, found that a peptide, or small piece of […]
READ MORE

You may have seen the news about a new app, called BiliScreen, being developed at the University of Washington that […]
READ MORE

“This is a meeting like no other – and this is an organization like no other!” Thus began the Pancreatic […]
READ MORE

A Pancreatic Cancer Action Network Career Development Award in 2014 allowed David DeNardo, PhD, to ask and answer important questions […]
READ MORE

The cleverly named The Cancer Genome Atlas project – abbreviated TCGA, in homage to the four base pairs that make […]
READ MORE

When Nada Kalaany, PhD, set out to establish an independent lab at Boston Children’s Hospital, she was determined to answer […]
READ MORE

One of the biggest challenges faced by scientists trying to solve lingering mysteries about the biology of pancreatic cancer is […]
READ MORE

The chemotherapy gemcitabine is widely used to treat pancreatic cancer patients. However, many patients develop resistance to the drug, leading […]
READ MORE

We are delighted to announce the addition of five national leaders in the pancreatic cancer space to our prestigious Scientific […]
READ MORE

Imagine that your doctor just told you that you have a cyst on your pancreas. She informs you that the […]
READ MORE

Earlier this month, nearly 40,000 clinical oncologists, cancer researchers and other healthcare and industry professionals convened in Chicago for the […]
READ MORE

Editor’s note: Keytruda was the first cancer drug approved to treat any solid tumor – anywhere in the body – […]
READ MORE

A study presented at an esteemed plenary session of the American Society of Clinical Oncology (ASCO) Annual Meeting and published […]
READ MORE

The American Association for Cancer Research (AACR) is spearheading a large-scale molecular profiling effort called Project Genomics Evidence Neoplasia Information […]
READ MORE

Last week, we shared the exciting news that an immunotherapy agent, Keytruda, was the first drug approved by the FDA […]
READ MORE

For the first time, the U.S. Food and Drug Administration (FDA) has approved a cancer drug based only on molecular […]
READ MORE

Editor’s note: This story was originally published in 2016, but we are sharing it again this month in celebration and […]
READ MORE

An all-star collaboration between three Pancreatic Cancer Action Network research grant recipients, representing three different institutions, has shown that immune […]
READ MORE

Two new research studies offer encouraging steps toward developing effective therapies to target the notoriously challenging RAS mutations. About 95 […]
READ MORE

The Pancreatic Cancer Action Network’s state-of-the-art Know Your Tumor® precision medicine service offers molecular profiling to eligible patients. Molecular profiling […]
READ MORE

The rationale behind the Pancreatic Cancer Action Network’s revolutionary Know Your Tumor® precision medicine service is to use molecular profiling […]
READ MORE

A new study published in the Journal of the American College of Surgeons finds that pancreatic cancer patients who travel […]
READ MORE

Research funding is critical to improving pancreatic cancer patient outcomes. But unfortunately, there simply isn’t enough of it. A study […]
READ MORE

A collaborative effort between researchers at the Fred Hutchinson Cancer Research Center, the University of Washington and Massachusetts Institute of […]
READ MORE

A novel peptide (small piece of protein) developed by a Pancreatic Cancer Action Network grantee was shown to benefit a […]
READ MORE

Last week, nearly 22,000 cancer researchers from around the world gathered in Washington, D.C., for the largest-ever American Association for […]
READ MORE

The more researchers analyze the interaction between pancreatic cancer cells and the patient’s immune system, the more complex the relationship […]
READ MORE

Grantees and scientific leadership celebrating at awards dinner On the evening of Tuesday, April 4, the Pancreatic Cancer Action Network (PanCAN), […]
READ MORE

As a risk factor, smoking is thought to contribute to about 20 percent of pancreatic cancer cases. Now, new research […]
READ MORE

The Pancreatic Cancer Action Network’s Scientific & Medical Affairs team acknowledged for key contributions to a study analyzing the pancreatic […]
READ MORE

On March 23 and 24, Julie Fleshman, JD, MBA, the Pancreatic Cancer Action Network’s president and CEO, was invited to […]
READ MORE

Last year, a staggering 1.7 million Americans were diagnosed with cancer – and more than 15.5 million people were living […]
READ MORE

What would you do with $1 million to improve outcomes for pancreatic cancer patients? A diverse group of seven research […]
READ MORE

It’s not every day that more than 450 pancreatic cancer researchers get together to talk about key topics in the […]
READ MORE

The fight against cancer is deeply personal for former Vice President Joe Biden, who lost his son, Beau, to brain […]
READ MORE

Meet Vincent Picozzi, Jr., MD, director of the pancreaticobiliary program at the Floyd & Delores Jones Cancer Institute at Virginia […]
READ MORE

We are delighted to report that our grantee, Brian Wolpin, MD, MPH, has been appointed Robert T. and Judith B. […]
READ MORE

The deadliest cancers in the United States are defined by the Recalcitrant Cancer Research Act, legislation the Pancreatic Cancer Action […]
READ MORE

There is a complex relationship between diabetes and pancreatic cancer – diabetes can be considered both a symptom and a […]
READ MORE

Changes that cause a normal cell to become cancerous are often genetic in nature – mutations or altered expression of […]
READ MORE

Aspirin and its potential to reduce the risk of pancreatic cancer has been a topic making headlines the past few […]
READ MORE

Researchers and clinicians have spent decades trying to devise ways to stop the growth and aggressive properties of pancreatic cancer […]
READ MORE

In April 2016, Jiyoung Ahn, PhD, recipient of the 2012 The Daniel and Janet Mordecai – Career Development Award, presented […]
READ MORE

On September 7, 2016, the Cancer Moonshot Blue Ribbon Panel released a report describing 10 recommendations to make a decade’s […]
READ MORE

Our Annual Scientific Meeting took place August 18 – 21 in beautiful San Diego, bringing together research grant recipients, current […]
READ MORE

One of the reasons that pancreatic cancer is particularly challenging to clinicians is that the majority of cases are diagnosed […]
READ MORE

Pancreatic cancer recently moved from the fourth to the third leading cause of cancer-related death in the United States, and […]
READ MORE

A rigorous analysis of 25 years’ worth of pancreatic cancer clinical trial data was published on June 6, 2016, in […]
READ MORE

From April 16 to April 20, nearly 20,000 cancer researchers from around the world gathered in New Orleans for the […]
READ MORE

In an insightful study published in the major journal Cell Stem Cell, Timothy Wang, MD, together with his colleagues and […]
READ MORE

The discovery of a new mode of pancreatic cancer cell death may play an important role in cancer cells’ survival.

Preliminary results from an early-phase immunotherapy clinical trial suggest that an innovative treatment could be effective for patients with locally-advanced or borderline-resectable pancreatic cancer.